Sign up to get updates from us
GeNeuro's CEO, Jesus Martin-Garcia, a consummate technology entrepreneur, tells his business journey from the birth of telecoms, to the advent of online grocery shopping, to his support and exploration of the final frontier in healthcare - biotechnology. GeNeuro is using human endogenous retroviruses (HERVs) to treat autoimmune diseases, including MS, ALS, and the lasting neurological symptoms of COVID-19.
